Galactan induces macrophage M0 to M1 conversion to combat colon cancer

  • Yue Meng
  • , Guang Yang
  • , Ai Ren
  • , Yunhe Qu
  • , Xue Wang
  • , Kevin H. Mayo
  • , Yifa Zhou
  • , Chengcheng Song

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

A 3-O-methylated-galactan WCCP-N-b from Cantharellus cibarius polarizes RAW264.7 macrophages, bone marrow-derived macrophages (BMDMs), and peritoneal macrophages (PEMs) leading to enhanced secretion of cytokine TNF-α and subsequent cytotoxic effects on HCT116 and CT26 colon cancer cells. Investigation into the mechanism of action suggests that WCCP-N-b polarizes macrophages by targeting Toll-like receptor 2 and activation of MAPKs and NF-κB signaling pathways. Overall, our results indicate that this linear 3-O-methylated-galactan inhibits colon cancer cells via conversion of M0 to M1 macrophages.

Original languageEnglish (US)
Pages (from-to)75-82
Number of pages8
JournalFood Science and Technology Research
Volume30
Issue number1
DOIs
StatePublished - 2024

Bibliographical note

Publisher Copyright:
© 2024 Japanese Society for Food Science and Technology. All rights reserved.

Keywords

  • antitumor effect
  • Cantharellus cibarius
  • galactan
  • macrophages

Fingerprint

Dive into the research topics of 'Galactan induces macrophage M0 to M1 conversion to combat colon cancer'. Together they form a unique fingerprint.

Cite this